Estradiol topical - LaSalle Laboratories

Drug Profile

Estradiol topical - LaSalle Laboratories

Alternative Names: Estradiol gel - LaSalle Laboratories; Estrogel; OEstroGel

Latest Information Update: 02 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator LaSalle Laboratories
  • Developer Abbott Laboratories; LaSalle Laboratories
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Atrophic vaginitis; Menopausal syndrome; Vasomotor symptoms

Most Recent Events

  • 05 Aug 2014 ASCEND Therapeutics and Aeterna Zentaris agree to co-promote estradiol topical in USA for Menopausal syndrome
  • 20 Aug 2013 Biomarkers information updated
  • 04 Apr 2011 Launched for Menopausal syndrome in Chile (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top